Schenectady, NY – June 5th, 2024 – EndoSoft® proudly announces the issuance of a new patent (US-11923054-B2) by the U.S. Patent and Trademark Office for Argus®. This groundbreaking AI platform is engineered to process speech and video data collected during medical procedures, marking a significant leap forward in healthcare documentation. With this innovative technology, medical professionals can streamline their workflow and dedicate more time to patient care.
“I am thrilled by the groundbreaking work accomplished by our research and development team here at EndoSoft® in securing this patent for our natural language processing software,” stated Rakesh K. Madan, President & CEO of EndoSoft®. “Enabling clinicians across various specialties within the healthcare space to save time on clinical documentation with seamless integration will have enduring positive effects throughout the medical field.”
EndoSoft®’s patented AI platform addresses the persistent challenge of time-consuming documentation processes encountered by doctors and clinicians. By harnessing advanced natural language processing and image classification techniques, the platform efficiently extracts clinical information from unstructured data and image data collected during procedures. This information is then structured and integrated seamlessly into medical reports, electronic health records, and quality-of-care indicators.
Key features of the AI platform include:
- Natural language processing (NLP) system: Converts speech into text, parses sentences, identifies text-based QIs, and classifies sentences into sentence types using a trained model. The system can also filter out irrelevant information.
- Output module: Organizes structured data, including sentences and images, for output in various formats such as medical reports, EMRs, or quality-of-care indicator registries. The AI platform is particularly well-suited for endoscopy procedures and other medical fields where the volume of procedures performed is high, and quality-of-care indicators play a crucial role in diagnosis and treatment. Its seamless integration with existing medical devices, medical records, and reporting systems ensures easy adoption within healthcare facilities.
Argus® represents a patented AI technology that enhances the suite of software offerings available from EndoSoft®.
About Argus®:
Argus® is an AI procedure documentation software which allows you to complete your procedure documentation during the procedure, using only your voice. Adding Argus® intelligent report writer to your workflow gives you time back in your day using Natural Language Processing (NLP) to complete procedure documentation. Argus® allows you to label images, document your procedure report, and auto-capture and record quality measures in real-time. Save time with AI procedure documentation.
Argus® is a vendor-neutral AI technology that integrates with existing EHRs/ERWs, endoscopes, and processors without changing your existing workflow.
Polyp detection & sizing functionalities of Argus® are NOT available in the United States. For information on current offerings, you can visit the official Argus® website.
About EndoSoft®
From a solo provider’s practice to large multi-specialty hospital systems, EndoSoft® applications are used by more than 100,000 clinical users worldwide, becoming one of the most trusted names in healthcare technology. EndoSoft®’s offerings include EndoVault®, a market-leading EMR tailored for a multitude of endoscopic specialties, including gastroenterology, ENT, OB/GYN, pathology, orthopedics, cardiology, pain management, pulmonology, oncology, ophthalmology, dermatology, and urology. The software is comprised of modules for procedure documentation, image management, nursing, reporting, scheduling, and inventory management. EndoVault® is also compliant with multiple international standards, including Meaningful Use and IHE.
EndoVault® is the most advanced EHR on the market today, offering a complete inpatient and ambulatory multi-specialty ONC Health IT Certified EHR.
Disclaimer: Argus® is clinical decision support software that functions within an EMR and is not intended for use as a medical device. It does not make a diagnosis, identify suspected adenomas, or direct treatment decisions, but it does organize information for the clinicians relating to polyps. It is not intended to substitute for the advice of a clinician. The clinician should always use proper judgment in patient care and should disregard Argus’s recommendations where clinically appropriate.
For media inquiries or further information, please contact:
Michael Papa
Marketing Coordinator
EndoSoft®
518-831-8000
mpapa@endosoft.com
